Publications by authors named "V Balloy"

is a saprophytic fungus and opportunistic pathogen often causing fatal infections in immunocompromised patients. Recently KDNAse, an exoglycosidase hydrolyzing 3-deoxy-D-galacto-D--nonulosonic acid (KDN), a rare sugar from the sialic acid family, was identified and characterized. The principal function of KDNAse is still unclear, but a study suggests a critical role in fungal cell wall morphology and virulence.

View Article and Find Full Text PDF

Aspergillus fumigatus is the predominant fungal species causing pulmonary aspergillosis. The present-day anti-aspergillosis arsenal is limited, with a number of molecules occasioning severe side effects (amphotericin B) or provoking significant drug interactions (azole derivatives). Moreover, the recent emergence of azole-resistant A.

View Article and Find Full Text PDF

Bronchial epithelial cells (BEC) play a crucial role in innate immunity against inhaled fungi. Indeed, in response to microorganisms, BEC synthesize proinflammatory cytokines involved in the recruitment of neutrophils. We have recently shown that BEC exert antifungal activity against by inhibiting filament growth.

View Article and Find Full Text PDF

In the coronavirus disease 2019 (COVID-19) health crisis, one major challenge is to identify the susceptibility factors of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) in order to adapt the recommendations for populations, as well as to reduce the risk of COVID-19 development in the most vulnerable people, especially patients with chronic respiratory diseases such as cystic fibrosis (CF). Airway epithelial cells (AECs) play a critical role in the modulation of both immune responses and COVID-19 severity. SARS-CoV-2 infects the airway through the receptor angiotensin-converting enzyme 2, and a host protease, transmembrane serine protease 2 (TMPRSS2), plays a major role in SARS-CoV-2 infectivity.

View Article and Find Full Text PDF
Article Synopsis
  • Scedosporium apiospermum is a harmful fungal pathogen that can cause severe infections in humans, and its interaction with host cells involves specific proteins called lectins that are potential targets for new therapies.
  • Researchers identified a new lectin from this fungus, called SapL1, which is similar to a lectin from another fungus known to help in adhesion to human lung cells.
  • The study detailed how SapL1 can be produced in bacteria, its strong preference for fucose sugar, and its ability to bind to human bronchial cells through this sugar, laying the groundwork for developing treatments targeting this lectin.
View Article and Find Full Text PDF